Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Shareholders' Equity / (Deficit)

v3.25.0.1
Consolidated Statements of Shareholders' Equity / (Deficit) - USD ($)
$ in Thousands
Total
Ordinary Shares
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Gain / ( Loss)
Beginning balance at Dec. 31, 2021 $ 50,234 $ 122 $ 428,605 $ (378,493)  
Beginning balance (in shares) at Dec. 31, 2021   12,185,019      
Issuance of ordinary shares, net 441 $ 4 437    
Issuance of ordinary shares, net (in shares)   413,622      
Share-based compensation expense 4,758   4,758    
Cancellation of share options 17,350   17,350    
Net Income (Loss) (44,434)     (44,434)  
Unrealized income (loss) on available-for-sale securities (350)       $ (350)
Ending balance at Dec. 31, 2022 27,999 $ 126 451,150 (422,927) (350)
Ending balance (in shares) at Dec. 31, 2022   12,598,641      
Issuance of ordinary shares, net 1,034 $ 7 1,027    
Issuance of ordinary shares, net (in shares)   732,763      
Share-based compensation expense 784   784    
Issuance of ordinary shares on conversion of exchangeable notes 1,800 $ 2 1,798    
Issuance of ordinary shares on conversion of exchangeable notes (in shares)   167,599      
Net Income (Loss) (38,371)     (38,371)  
Unrealized income (loss) on available-for-sale securities 351       351
Ending balance at Dec. 31, 2023 (6,403) $ 135 454,759 (461,298) 1
Ending balance (in shares) at Dec. 31, 2023   13,499,003      
Issuance of ordinary shares, net 22,117 $ 164 21,953    
Issuance of ordinary shares, net (in shares)   16,449,752      
Share-based compensation expense 363   363    
Issuance of warrants for ordinary shares 2,718   2,718    
Exercise of warrants for ordinary shares 1,812 $ 15 1,797    
Exercise of warrants for ordinary shares (in shares)   1,498,145      
Exercise of share options $ 87 $ 1 86    
Exercise of share options (in shares) 87,333 87,333      
Net Income (Loss) $ (24,774)     (24,774)  
Unrealized income (loss) on available-for-sale securities (1)       $ (1)
Ending balance at Dec. 31, 2024 $ (4,081) $ 315 $ 481,676 $ (486,072)  
Ending balance (in shares) at Dec. 31, 2024   31,534,233